Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.83%2.28B | 5.32%1.74B | 3.76%7.18B | -21.73%1.66B | 26.72%1.71B | 1.48%2.15B | 24.75%1.66B | -17.35%6.92B | 1.10%2.12B | -16.59%1.35B |
Cost of revenue | 6.28%1.76B | 2.70%1.37B | 3.44%5.73B | -19.66%1.4B | 25.84%1.35B | 3.06%1.65B | 18.43%1.33B | -17.18%5.54B | 3.77%1.74B | -17.32%1.07B |
Gross profit | 4.36%522.79M | 16.10%375.7M | 5.03%1.45B | -31.29%259.62M | 30.07%363.74M | -3.41%500.96M | 59.89%323.58M | -18.01%1.38B | -9.59%377.83M | -13.67%279.65M |
Operating expense | -0.66%411.59M | 2.60%391.54M | -3.19%1.59B | 3.89%412.04M | -3.07%378.91M | -1.28%414.34M | -11.65%381.63M | -8.11%1.64B | -5.76%396.61M | -7.80%390.92M |
Staff costs | ---- | ---- | -5.44%809.31M | ---- | ---- | ---- | ---- | -8.24%855.9M | ---- | ---- |
Selling and administrative expenses | ---- | ---- | 0.74%435.44M | ---- | ---- | ---- | ---- | -3.19%432.22M | ---- | ---- |
-Selling and marketing expense | ---- | ---- | -19.61%41.13M | ---- | ---- | ---- | ---- | 7.42%51.16M | ---- | ---- |
-General and administrative expense | ---- | ---- | 3.48%394.31M | ---- | ---- | ---- | ---- | -4.46%381.06M | ---- | ---- |
Depreciation and amortization | ---- | ---- | -38.33%29.56M | ---- | ---- | ---- | ---- | -18.72%47.93M | ---- | ---- |
-Depreciation | ---- | ---- | -38.33%29.56M | ---- | ---- | ---- | ---- | -18.72%47.93M | ---- | ---- |
Rent and land expenses | ---- | ---- | -6.05%79.99M | ---- | ---- | ---- | ---- | -11.96%85.14M | ---- | ---- |
Other operating expenses | ---- | ---- | 6.71%232.61M | ---- | ---- | ---- | ---- | -12.43%217.98M | ---- | ---- |
Operating profit | 28.36%111.19M | 72.71%-15.84M | 46.67%-139M | -711.77%-152.42M | 86.37%-15.16M | -12.46%86.62M | 74.72%-58.05M | -154.05%-260.66M | -540.60%-18.78M | -11.18%-111.26M |
Net non-operating interest income (expenses) | 67.66%-3.32M | 59.53%-3.76M | 5.29%-39M | -5.14%-9.68M | 3.10%-9.75M | 8.13%-10.27M | 13.33%-9.3M | 1.59%-41.17M | 12.57%-9.21M | -0.02%-10.06M |
Non-operating interest income | --0 | 100.00%4K | -16.67%5K | --0 | -99.20%3K | --0 | -33.33%2K | -14.29%6K | -18,800.00%-374K | 9,325.00%377K |
Non-operating interest expense | -67.66%3.32M | -59.49%3.77M | -5.29%39M | 9.59%9.68M | -6.57%9.76M | -8.13%10.27M | -13.34%9.3M | -1.59%41.18M | -16.13%8.83M | 3.73%10.44M |
Net investment income | 130.77%30K | -41.61%3.76M | 3.23%29.28M | 18.28%8.33M | -9.04%14.49M | -75.93%13K | 20.78%6.45M | 36.00%28.36M | 5.70%7.05M | 60.11%15.93M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 21.95%90.05M | -107.51%-5.54M | 3K | -29.73%73.84M | 1,763.71%73.84M | 0 | ||||
Income from associates and other participating interests | 431.03%10.68M | 147.08%7.37M | -184.59%-17.11M | -705.31%-17.67M | -83.87%802K | -149.18%-3.23M | -48.39%2.98M | 4.59%20.23M | -23.92%2.92M | -20.15%4.97M |
Special income (charges) | 0 | 0 | 511.77%1.47B | 545.53%1.48B | -127.26%-11.27M | 0 | 0 | -357.69M | -333.11M | -4.96M |
Less:Restructuring and mergern&acquisition | ---- | ---- | --119.03M | --107.76M | ---- | ---- | ---- | --0 | --0 | ---- |
Less:Other special charges | ---- | ---- | -6,577.64%-1.59B | ---- | ---- | ---- | ---- | --24.58M | --0 | --4.96M |
Less:Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --333.11M | ---- | ---- |
Other non-operating income (expenses) | 119.56%3.96M | 46.32%3.64M | 0.55%-12.44M | -154.36%-379K | -28.51%5.72M | 27.70%-20.27M | -67.59%2.49M | -136.67%-12.51M | -124.71%-149K | 467.80%8M |
Income before tax | -17.46%122.55M | 91.28%-4.83M | 351.93%1.38B | 570.99%1.31B | 84.41%-15.18M | 125.03%148.46M | 76.98%-55.43M | -1,672.77%-549.6M | -17,440.50%-277.45M | -1.30%-97.39M |
Income tax | 315.86%28.15M | 101.43%3.38M | 870.49%170.47M | 32,655.41%432.99M | -316.14%-13.52M | -334.77%-13.04M | -3,430.42%-235.96M | -53.38%17.57M | -111.72%-1.33M | 158.24%6.26M |
Net income | -41.55%94.4M | -104.55%-8.22M | 314.07%1.21B | 416.45%873.77M | 98.40%-1.66M | 167.30%161.5M | 172.85%180.53M | -20,667.78%-567.17M | -2,732.26%-276.12M | -21.37%-103.65M |
Net income continuous operations | -41.55%94.4M | -104.55%-8.22M | 314.07%1.21B | 416.45%873.77M | 98.40%-1.66M | 167.30%161.5M | 172.85%180.53M | -20,667.78%-567.17M | -2,732.27%-276.12M | -21.37%-103.65M |
Noncontrolling interests | -80.60%182K | -135.36%-262K | 47.62%-594K | -1,362.50%-808K | 28.57%-1.47M | 47.48%938K | 241.47%741K | -143.02%-1.13M | 152.03%64K | -1,019.73%-2.05M |
Net income attributable to the company | -41.32%94.22M | -104.42%-7.96M | 314.61%1.21B | 416.67%874.58M | 99.81%-193K | 168.57%160.57M | 172.48%179.79M | -10,446.56%-566.03M | -2,769.42%-276.18M | -18.66%-101.6M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -41.32%94.22M | -104.42%-7.96M | 314.61%1.21B | 416.67%874.58M | 99.81%-193K | 168.57%160.57M | 172.48%179.79M | -10,446.56%-566.03M | -2,769.42%-276.18M | -18.66%-101.6M |
Gross dividend payment | ||||||||||
Basic earnings per share | -41.32%55.31 | -104.42%-4.67 | 314.61%713.11 | 416.67%513.42 | 99.82%-0.11 | 168.55%94.26 | 172.48%105.54 | -10,448.57%-332.28 | -2,769.56%-162.13 | -18.66%-59.64 |
Diluted earnings per share | -41.32%55.31 | -104.42%-4.67 | 314.61%713.11 | 416.67%513.42 | 99.81%-0.1133 | 168.57%94.2582 | 172.48%105.54 | -10,448.57%-332.28 | -2,769.44%-162.13 | -18.66%-59.6407 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |